Showing results (121-130 of 263) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.The New England Journal of Medicine|May 1, 1997
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphomaA M Gianni, M Bregni, S Siena, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancerL Licitra, L D Locati, R Cavina, et al.Tumori|February 28, 1982
Evaluation of lung ventilation and carbon monoxide-diffusing capacity in patients with nonseminomatous testicular tumors treated with bleomycinA Pagnoni, G Riboldi, P ValagussaActa Haematologica|January 1, 1987
Guidelines to modern treatment of non-Hodgkin's lymphomasG Bonadonna, E BajettaControlled Clinical Trials|December 1, 1985
The use of historical controls in breast cancer. An assessment in three consecutive trialsR Micciolo, P Valagussa, E MarubiniBlood Reviews|March 1, 1990
Current issues in the management of advanced Hodgkin's diseaseG Bonadonna, A SantoroCancer Chemotherapy and Pharmacology|January 1, 1979
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)A Santoro, G BonadonnaAnticancer Research|July 1, 1987
Prognostic factors and response to treatment in non-Hodgkin's lymphomas (review)G Bonadonna, G S JottiAnticancer Research|July 1, 1988
Prognostic factors in Hodgkin's disease: implications for modern treatment (review)G S Jotti, G BonadonnaPageof 27